Wenzel, Nicolas
Wittayer, Matthias
Weber, Claudia E.
Schirmer, Lucas http://orcid.org/0000-0001-7142-4116
Platten, Michael http://orcid.org/0000-0002-4746-887X
Gass, Achim
Eisele, Philipp http://orcid.org/0000-0001-6831-4282
Funding for this research was provided by:
Medizinische Fakultät Mannheim der Universität Heidelberg
Article History
Received: 10 February 2022
Revised: 11 March 2022
Accepted: 11 March 2022
First Online: 25 March 2022
Declarations
:
: This study was approved by the local ethics committee (Ethikkommission II, Medical Faculty Mannheim, Heidelberg University, 2017-830R-MA) and performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Patient consent was waived due to the retrospective nature of the study and the lack of patient interaction.
: Nicolas Wenzel reports no disclosures; Matthias Wittayer reports personal fees from Novartis, Alnylam, Amicus, Biogen, Bristol-Myers-Squibb, Pfizer, Bial, other from Boehringer-Ingelheim Foundation; Claudia E. Weber reports no disclosures; Lucas Schirmer reports no disclosures; Michael Platten has a consultant relationship with Novartis, Merck, Genentech/Roche, has received non-personal, institutional honoraria from Medac, Merck, Novartis, TEVA, Genentech/Roche and has research agreements with Bayer Health Care; Achim Gass has received honoraria for lecturing, travel expenses for attending meetings, and financial support for research from Bayer Schering, Biogen Idec, Merck Serono, Novartis, TEVA Neurosciences and is member of the Editorial Board of the Journal of Neuroimaging; Philipp Eisele has received travel expenses from Bayer Health Care and is member of the Editorial Board of the Journal of Neuroimaging.